rociletinib
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
ABSTRACT Introduction: Significant advances have been made since the development of epidermal growth factor receptor tyrosine…
9001Background: Rociletinib is an oral inhibitor of mutant EGFR, including T790M. We compared EGFR mutation detection in…
9045Background: Rociletinib is an oral, irreversible tyrosine kinase inhibitor of mutant epidermal growth factor receptor…
ABSTRACT Introduction: Major advances have been made since the discovery of driver mutations and their targeted therapies…
8001 Background: Rociletinib is an oral inhibitor of mutant EGFR, including the T790M resistance mutation. We reported robust…
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA
Rociletinib (CO-1686) is a novel, oral…
TPS8109 Background: Rociletinib is a small molecule inhibitor that selectively targets mutant EGFR and has been shown in…